Transdermal Estradiol Therapy for Advanced Prostate Cancer—Forward to the Past?-Reference-Cited by-同舟云学术

Transdermal Estradiol Therapy for Advanced Prostate Cancer—Forward to the Past?

Published:2003-05 Issue:5 Volume:169 Page:1735-1737
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

OCKRIM J.L.¹,LALANI E.-N.¹,LANIADO M.E.¹,CARTER S. St. C.¹,ABEL P.D.¹

Affiliation:

1. From the Departments of Surgical Oncology and Technology, Histopathology, Faculty of Medicine, Imperial College and Department of Urology, Hammersmith Hospitals NHS Trust

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference15 articles.

1. Cancer Statistics, 2001

2. Cardiovascular and all-cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population

3. Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality

4. Mortality and morbidity in transsexual subjects treated with cross-sex hormones

5. Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2-year follow-up report of a national, prospective prostatic cancer study

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens;Biomedicines;2024-07-23

2. Cerebral effects of gender-affirming hormone treatments in transgender persons;Principles of Gender-Specific Medicine;2023

3. References;An Insider's Perspective of Prostate Cancer;2023

4. Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review;Endocrine Connections;2022-12-01

5. Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer;Asian Journal of Urology;2020-07